They are mostly all correct, and they are describing different things
Restarting medication after regain means paying for another full course of treatment, including the dose escalation phase where medication cost accrues without maximum benefit
Class Triple agonist at GIP, GLP-1, and glucagon receptors (synthetic peptide) Origin
Brand-name weekly injectables (Wegovy semaglutide, Zepbound tirzepatide) typically list between about $1,000 and $1,400 per 28-day supply when paid out of pocket, depending on dose and pharmacy
Supplementation Supplementing GLP-1 is a key way to reach adequate levels, which can be difficult through diet alone
But the shot uses a tiny insulin needle